Irritable Bowel Syndrome: The effect of FODMAPs and meditation on pain management

被引:1
|
作者
Cearley, Shannon M. [1 ]
Immaneni, Supriya [2 ]
Shankar, Padmini [3 ]
机构
[1] 1017 Iris Glen Dr, Evans, GA 30809 USA
[2] Northwestern Univ, Feinberg Sch Med, 333 East Ontario St,Apt 2513 B, Chicago, IL 60611 USA
[3] Georgia Southern Univ, POB 8076, Statesboro, GA 30460 USA
关键词
Irritable Bowel Syndrome; Integrative medicine; FODMAPs; Transient receptor potentials; Meditation; SYMPATHETIC-NERVOUS-SYSTEM; GASTROINTESTINAL SYMPTOMS; MINDFULNESS-MEDITATION; DOUBLE-BLIND; CHANNELS; TRPV1; MECHANISMS; MEDICINE; EFFICACY; HEALTH;
D O I
10.1016/j.eujim.2017.05.003
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Introduction: Irritable Bowel Syndrome (IBS) is a highly prevalent gastrointestinal disorder. Symptoms include abdominal pain, diarrhea, constipation, and bloating. IBS can significantly impact quality of life for patients. Similarity in symptoms can be attributed to other diseases, and the varied symptomatic manifestation among patients can cause physicians to have difficulty in providing a differential diagnosis, prolonging suffering. The heterogeneity of the disorder often forces physicians and patients to primarily focus on symptomatic management with pharmaceuticals, which can eventually lead to patient dissatisfaction due to the undesirable side effects sans quality of life improvement. Methods: We used articles found in PubMed, National Institutes of Health, and the Centers for Disease Control and Prevention to provide a review of literature that focuses on two alternative approaches to symptom management, meditation and diet. Evidence suggests these alternative approaches to pain management can be integrated with conventional therapy to attenuate pain in IBS by inhibiting transient receptor potential channels. Results: Within the last century, low FODMAP diets, along with relaxation through meditation, are areas that have received increased attention among medical professionals. Evidence suggests that dietary interventions, along with discovery and understanding of transient receptor potentials, have provided new insight into the mechanisms of action that are attributed to nociception in IBS. Conclusion: In this opinion paper, we offer information on evidence-based complementary therapies that have been reported to improve patient satisfaction in the management of pain related to IBS. It would behoove physicians and patients to utilize an integrative approach that includes conventional and proven alternative therapies for IBS treatment.
引用
收藏
页码:117 / 121
页数:5
相关论文
共 50 条
  • [41] Irritable bowel syndrome: diagnosis and management
    Masuy, Imke
    Pannemans, Jasper
    Tack, Jan
    MINERVA GASTROENTEROLOGICA E DIETOLOGICA, 2020, 66 (02) : 136 - 150
  • [42] MANAGEMENT OF IRRITABLE-BOWEL-SYNDROME
    KELLOW, JE
    EVANS, PR
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1993, 8 (03) : 287 - 293
  • [43] Rifaximin in the management of irritable bowel syndrome
    Lairani, F.
    Errami, A. Ait
    Oubaha, S.
    Krati, K.
    Samlani, Z.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 : 251 - 251
  • [44] Diagnosis and Management of Irritable Bowel Syndrome
    Rao, Satish S. C.
    Aziz, Abeer
    Asadi, Delaram
    PRACTICAL GASTROENTEROLOGY, 2024, 48 (12)
  • [45] MANAGEMENT OF IRRITABLE-BOWEL-SYNDROME
    PRIOR, A
    WHORWELL, PJ
    BIOMEDICINE & PHARMACOTHERAPY, 1986, 40 (01) : 4 - 5
  • [46] Best management of irritable bowel syndrome
    Black, Christopher J.
    Ford, Alexander Charles
    FRONTLINE GASTROENTEROLOGY, 2021, 12 (04) : 303 - 315
  • [47] Pharmacologic Management of Irritable Bowel Syndrome
    Rao, Vijaya L.
    Cifu, Adam S.
    Yang, Leslie W.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 314 (24): : 2684 - 2685
  • [48] Medication Management of Irritable Bowel Syndrome
    Trinkley, Katy E.
    Nahata, Milap C.
    DIGESTION, 2014, 89 (04) : 253 - 267
  • [49] Optimal management of irritable bowel syndrome
    Brierley, Rob
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2022, 7 (08): : 708 - 708
  • [50] Advances in the management of irritable bowel syndrome
    Brooks D. Cash
    William D. Chey
    Current Gastroenterology Reports, 2003, 5 (6) : 468 - 475